Loading company details...
Latest Form 4 (Nov 16, 2026): Marco Maria Brughera (Director): Exercise/Conversion of 20,000 shares, $42.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 16, 2026 | Marco Maria Brughera | Exercise/Conversion | 20,000 | $42.2K |
| Nov 2, 2026 | Terry L. Evans, Chief Commercial Officer | Grant/Award | 168 | n/a |
| Nov 2, 2026 | Pierre Sargis Sayad, Chief Medical Officer | Grant/Award | 168 | n/a |
| Nov 2, 2026 | Jeffrey S. Hackman, Chief Executive Officer | Grant/Award | 1,159 | n/a |
| Nov 2, 2026 | Christiana Marie Cioffi, Chief Strategy Officer | Grant/Award | 156 | n/a |
| Nov 2, 2026 | Robert Andrade, CHIEF FINANCIAL OFFICER | Grant/Award | 1,703 | n/a |
| Oct 13, 2026 | Pierre Sargis Sayad, Chief Medical Officer | Grant/Award | 3,846 | $21.3K |
| Oct 13, 2026 | Jeffrey S. Hackman, Chief Executive Officer | Grant/Award | 2,224 | $12.3K |
| Oct 13, 2026 | Terry L. Evans, Chief Commercial Officer | Grant/Award | 2,326 | $12.9K |
| Oct 13, 2026 | Christiana Marie Cioffi, Chief Strategy Officer | Grant/Award | 3,946 | $21.8K |